Clinical Trials

    Showing 1 - 2 of 2 Atherosclerosis and Arteriosclerosis

    Status: Enrolling

    Investigator: Sadeer Al-Kindi

    Study Coordinator: Peyton Martin

    Phone: 346.356.3691

    TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the h... Read more >

    Status: Enrolling

    Investigator: Waleed Ahmed

    Study Coordinator:

    Phone:

    This study is a prospective, observational case control study that will generate preliminary data from 50 cases (South Asian) and 100 controls (50 South Asian and 50 non-South Asian) who have undergone clinically indicated CTAs. Participants will be ... Read more >